BOUNDLESS BIO, INC (NASDAQ:BOLD) IPO will take place March, 28 on the NASDAQ exchange under the ticker BOLD.
The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on September 24, 2024.
See also: Benzinga IPO Calendar
About BOUNDLESS BIO, INC
BOUNDLESS BIO, INC is a clinical-stage oncology company dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting ecDNA, a root cause of oncogene amplification observed in more than 14% of cancer patients.
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
